88 related articles for article (PubMed ID: 38627815)
1. Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells.
Zhong P; Nakata K; Oyama K; Higashijima N; Sagara A; Date S; Luo H; Hayashi M; Kubo A; Wu C; He S; Yamamoto T; Koikawa K; Iwamoto C; Abe T; Ikenaga N; Ohuchida K; Morisaki T; Oda Y; Kuba K; Nakamura M
J Exp Clin Cancer Res; 2024 May; 43(1):138. PubMed ID: 38715057
[TBL] [Abstract][Full Text] [Related]
2. Unveiling YWHAH: A potential therapeutic target for overcoming CD8
Li Q; Yuan Z; Wang Y; Zhai P; Wang J; Zhang C; Shao Z; Xing C
Int Immunopharmacol; 2024 Jun; 135():112317. PubMed ID: 38796965
[TBL] [Abstract][Full Text] [Related]
3. PACSIN1 promotes immunosuppression in gastric cancer by degrading MHC-I.
Liu Z; Li X; Muhammad A; Sun Q; Zhang Q; Wang Y; Wang Y; Ren J; Wang D
Acta Biochim Biophys Sin (Shanghai); 2024 Jun; ():. PubMed ID: 38826133
[TBL] [Abstract][Full Text] [Related]
4. Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer.
Pecci F; Cantini L; Bittoni A; Lenci E; Lupi A; Crocetti S; Giglio E; Giampieri R; Berardi R
Curr Treat Options Oncol; 2021 Jun; 22(8):69. PubMed ID: 34110510
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of autophagy-related protein 7 enhances anti-tumor immune response and improves efficacy of immune checkpoint blockade in microsatellite instability colorectal cancer.
Zhang W; Chen L; Liu J; Chen B; Shi H; Chen H; Qi H; Wu Z; Mao X; Wang X; Huang Y; Li J; Yu Z; Zhong M; Wang T; Li Q
J Exp Clin Cancer Res; 2024 Apr; 43(1):114. PubMed ID: 38627815
[TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022.
André T; Cohen R; Salem ME
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-9. PubMed ID: 35471834
[TBL] [Abstract][Full Text] [Related]
7. Discordant prognosis of mismatch repair deficiency in colorectal and endometrial cancer reflects variation in antitumour immune response and immune escape.
Glaire MA; Ryan NA; Ijsselsteijn ME; Kedzierska K; Obolenski S; Ali R; Crosbie EJ; Bosse T; de Miranda NF; Church DN
J Pathol; 2022 Jul; 257(3):340-351. PubMed ID: 35262923
[TBL] [Abstract][Full Text] [Related]
8. A TGFβ-Dependent Stromal Subset Underlies Immune Checkpoint Inhibitor Efficacy in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Colorectal Cancer.
Endo E; Okayama H; Saito K; Nakajima S; Yamada L; Ujiie D; Kase K; Fujita S; Endo H; Sakamoto W; Saito M; Saze Z; Momma T; Ohki S; Mimura K; Kono K
Mol Cancer Res; 2020 Sep; 18(9):1402-1413. PubMed ID: 32493700
[TBL] [Abstract][Full Text] [Related]
9. Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment.
Taieb J; Svrcek M; Cohen R; Basile D; Tougeron D; Phelip JM
Eur J Cancer; 2022 Nov; 175():136-157. PubMed ID: 36115290
[TBL] [Abstract][Full Text] [Related]
10. RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer.
Yamamoto Y; Shimada S; Akiyama Y; Tsukihara S; Sugimoto R; Kabashima A; Tokunaga M; Kinugasa Y; Kawakami Y; Tanaka S
J Gastroenterol; 2023 Jun; 58(6):540-553. PubMed ID: 36859628
[TBL] [Abstract][Full Text] [Related]
11. Immune synapse formation promotes lipid peroxidation and MHC-I upregulation in licensed dendritic cells for efficient priming of CD8
Calzada-Fraile D; Iborra S; Ramírez-Huesca M; Jorge I; Dotta E; Hernández-García E; Martín-Cófreces N; Nistal-Villán E; Veiga E; Vázquez J; Pasqual G; Sánchez-Madrid F
Nat Commun; 2023 Oct; 14(1):6772. PubMed ID: 37880206
[TBL] [Abstract][Full Text] [Related]
12.
Fong W; Li Q; Ji F; Liang W; Lau HCH; Kang X; Liu W; To KK; Zuo Z; Li X; Zhang X; Sung JJ; Yu J
Gut; 2023 Nov; 72(12):2272-2285. PubMed ID: 37770127
[TBL] [Abstract][Full Text] [Related]
13. Celastrol upregulated ATG7 triggers autophagy via targeting Nur77 in colorectal cancer.
Zhang W; Wu Z; Qi H; Chen L; Wang T; Mao X; Shi H; Chen H; Zhong M; Shi X; Wang X; Li Q
Phytomedicine; 2022 Sep; 104():154280. PubMed ID: 35752079
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol Metabolism as a Potential Therapeutic Target and a Prognostic Biomarker for Cancer Immunotherapy.
Zhang H; Zhao W; Li X; He Y
Onco Targets Ther; 2021; 14():3803-3812. PubMed ID: 34188488
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]